BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.32.0//EN
X-ORIGINAL-URL:https://cibm.ch/
X-WR-CALNAME:CIBM  |  Center for Biomedical Imaging
X-WR-CALDESC:
X-WR-TIMEZONE:Europe/Zurich
BEGIN:VTIMEZONE
TZID:Europe/Zurich
X-LIC-LOCATION:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=4SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-fafb6206d62f162cb7ba58187fd7d32c@cibm.ch
DTSTART;TZID=Europe/Zurich:20241016T110000
DTEND;TZID=Europe/Zurich:20241016T120000
DTSTAMP:20240924T103409Z
CREATED:20240924
LAST-MODIFIED:20241008
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:7T MRI Seminar: What is the current evidence of the diagnostic value of 7T MRI?
DESCRIPTION:Abstract\nEvidence-based medicine is the paradigm for both individual medical decisions and global healthcare policies. 7T MRI has been available as a clinically approved diagnostic tool since 2017; it seems timely to ask what body of comparative evidence exists for 7T MRI. We assessed the evidence of the diagnostic comparative features of 7T MRI compared to the standard of care (3T, 1.5T MRI or other clinically used imaging modalities) with a systematic literature search and intended meta-analysis. We will discuss the body of comparative evidence for the use of 7T MRI and identifying evidence gaps to motivate further research.\n\nPiotr Radojewski \nTranslational Imaging Center, SITEM-Insel, Bern, Switzerland\nDr. Piotr Radojewski is the Managing Director of the Translational Imaging Center at SITEM-Insel. He is Holder of an MD in human medicine and is engaged in both scientific and clinical work at the Institute for Diagnostic and Interventional Neuroradiology at Inselspital. His responsibilities include coordinating research projects and collaborating with industry, with a particular focus on ultra-high-field MRI. Dr. Radojewski brings extensive expertise at the intersection of clinical medicine, research, and industry. He is a graduate of an executive education program at Stanford Graduate School of Business and a design-thinking program at the Hasso Plattner Institute. He has experience advising companies on transitioning research projects into market-ready products and has acted as an early-stage investor.\nDate and time\nWednesday, October 16th, 2024, 11:00 to 12:00 pm CEST\nLocation\nVirtual on Zoom and on-site at Campus Biotech Room H8-01-F.\nJOIN US!\n\nIf attending on-site, no registration is required.\nPlease join here via Zoom (Meeting ID: 654 0494 5981)\n
URL:https://cibm.ch/event/7t-mri-seminar-what-is-the-current-evidence-of-the-diagnostic-value-of-7t-mri/
CATEGORIES:7T MRI Seminar Series,Talk
LOCATION:Campus Biotech H8-01-F or online
END:VEVENT
END:VCALENDAR